Endothelial SHMT2 Drives Pulmonary Vascular Remodeling Through Noncanonical Pathway in Pulmonary Hypertension
Circulation · 25.08.2026 · 154 (8) · 750-770
DOI: 10.1161/circulationaha.125.066183 ↗Kurz gefasst
Fachartikel in der Zeitschrift Circulation, erschienen am 25.08.2026. Verfasst von Qianqian Wang und 18 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory for Innovation and Transformation of Luobing Theory; Key Laboratory of Cardiovascular Remodeling and Function Research, Chinese …. Hauptthemen laut MEDLINE: Hypertension, Pulmonary, Glycine Hydroxymethyltransferase, Vascular Remodeling, Endothelial Cells. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 68 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Pulmonary hypertension (PH) is a progressive, life-threatening disease characterized primarily by pulmonary vascular remodeling in which endothelial dysfunction plays a vital role. However, the molecular factors contributing to this pathological process remain incompletely understood. Through proteomic analysis of hypoxia-treated human pulmonary artery endothelial cells, we identified serine hydroxymethyltransferase 2 (SHMT2) as a potential target in PH, but its role in disease pathogenesis and the underlying mechanisms remain unclear. METHODS: The expression and function of SHMT2 were assessed in lung samples from patients with PH and in rodent PH models, including hypoxia-exposed mice and monocrotaline- or Sugen 5416/hypoxia–induced rats. Endothelial cell–specific SHMT2 loss and gain of function were achieved by conditional knockout and adeno-associated virus 9–mediated gene modulation. In vitro studies were performed in hypoxia-treated human pulmonary artery endothelial cells and HEK-293T cells. Virtual screening was used to identify a small-molecule inhibitor targeting the nonmetabolic function of SHMT2, and its therapeutic potential was further evaluated in rodent PH models. RESULTS: SHMT2 was upregulated predominantly in pulmonary vascular endothelium of patients with PH and multiple rodent PH models. In vivo, endothelial cell–specific deletion of Shmt2 markedly attenuated pulmonary vascular remodeling and right ventricular dysfunction in PH mice, whereas endothelial cell–specific Shmt2 overexpression aggravated PH development. Consistently, adeno-associated virus 9–mediated endothelial Shmt2 knockdown alleviated PH phenotypes in rat models. Mechanistically, SHMT2 promoted hypoxia-induced endothelial barrier dysfunction mainly through a noncanonical function by blocking the K63-ubiquitin–mediated lysosomal degradation of ras homolog family member B (RhoB). Additional in vivo studies supported an important role of the endothelial SHMT2-RhoB axis in pulmonary vascular remodeling of PH. Through virtual screening, Namodenoson was identified as a small-molecule inhibitor targeting the SHMT2-RhoB pathway. In vivo, Namodenoson showed both preventive and therapeutic effects against PH. CONCLUSIONS: This study highlights endothelial SHMT2 as an important contributor to PH pathogenesis and reveals a noncanonical SHMT2-RhoB pathway that promotes endothelial dysfunction. Targeting this pathway may represent a potential therapeutic strategy for PH.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory for Innovation and Transformation of Luobing Theory; Key Laboratory of Cardiovascular Remodeling and Function Research, Chinese Ministry of Education, Chinese National Health Commission and Chinese…
- Department of Cardiology, The Affiliated Hospital of Qingdao University, Shandong, China (Q.W., J.L.).
- Department of Cardiology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, China (J.T.).
- Key Laboratory of Infection Immunity and Disease Intervention of Shandong Province and Department of Immunology, School of Basic Medical Sciences, Cheeloo College of Medicine, Shandong University, Jinan, China (F.L., Y.…
- Department of Physiology and Pathophysiology, School of Basic Medical Sciences, Cheeloo College of Medicine, Shandong University, Jinan, China (S.D.).
ORCID-Profile: Qianqian Wang, Tengfei Zheng, Xiao Li, Shanshan Wang, Wencheng Zhang, Meng Zhang, Cheng Zhang, Mei Zhang, Shen Dai
Zitieren
APA
Wang, Q., Tian, J., Liu, D., Zheng, T., Liu, X., Zhao, Y., Li, X., Zhong, H., Pan, J., Yuan, C., Zhao, Y., Wang, S., Li, J., Zhang, W., Zhang, M., Zhang, C., Liu, F., Zhang, M., & Dai, S. (2026). Endothelial SHMT2 Drives Pulmonary Vascular Remodeling Through Noncanonical Pathway in Pulmonary Hypertension. Circulation, 154(8), 750-770. https://doi.org/10.1161/circulationaha.125.066183
Vancouver
Wang Q, Tian J, Liu D, Zheng T, Liu X, Zhao Y, et al. Endothelial SHMT2 Drives Pulmonary Vascular Remodeling Through Noncanonical Pathway in Pulmonary Hypertension. Circulation. 2026;154(8):750-770. doi:10.1161/circulationaha.125.066183
BibTeX
@article{Wang2026,
author = {Wang, Qianqian and Tian, Jingjing and Liu, Dongdong and Zheng, Tengfei and Liu, Xiaolin and Zhao, Yachao and Li, Xiao and Zhong, Hongyu and Pan, Jichen and Yuan, Chong and Zhao, Yuliang and Wang, Shanshan and Li, Jian and Zhang, Wencheng and Zhang, Meng and Zhang, Cheng and Liu, Fengming and Zhang, Mei and Dai, Shen},
title = {Endothelial SHMT2 Drives Pulmonary Vascular Remodeling Through Noncanonical Pathway in Pulmonary Hypertension},
journal = {Circulation},
year = {2026},
volume = {154},
number = {8},
pages = {750--770},
doi = {10.1161/circulationaha.125.066183}
}
EUVIMED